Related Experiment Video

Updated: May 17, 2026

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Platelet function in ischemic heart disease

Susanne M Picker1

  • 1Transfusion Medicine, University Hospital of Cologne, Cologne, Germany. susanne.picker@uk-koeln.de

Journal of Cardiovascular Pharmacology
|October 31, 2012
PubMed

Insights

Blood platelets (PLTs) are crucial in atherothrombosis and cardiovascular events. This review details current anti-PLT therapies and emerging drugs for preventing serious cardiovascular events, addressing treatment variability.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Pharmacology

Background:

  • Blood platelets (PLTs) are central to atherothrombosis and thrombus formation following atherosclerotic plaque rupture.
  • Anti-PLT therapy is standard for patients undergoing cardiopulmonary bypass grafting.
  • Platelets interact with vascular cells, contributing to inflammation and fibroproliferation, impacting outcomes.

Purpose of the Study:

  • To review the established role of platelets in hemostasis and atherothrombosis.
  • To summarize the current landscape of anti-platelet (anti-PLT) therapies.
  • To highlight novel anti-PLT agents for cardiovascular event prevention.

Main Methods:

  • Literature review of clinical trials and existing research on anti-PLT therapy.
  • Analysis of platelet interactions in vascular inflammation and fibroproliferation.
  • Evaluation of current and emerging anti-PLT drug efficacy and limitations.

Main Results:

  • Platelet function blockade is effective in preventing acute coronary syndromes.
  • Platelet inhibition is widely used in cardiopulmonary bypass grafting.
  • Variability in response to anti-PLT drugs can lead to adverse outcomes and increased interventions.

Conclusions:

  • Platelets are critical in cardiovascular pathophysiology, necessitating effective anti-PLT strategies.
  • Current anti-PLT therapies offer benefits but face challenges like response variability.
  • New anti-PLT drugs show promise in improving prevention of serious cardiovascular events.

More Related Videos

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow11:42

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow

Published on: July 10, 2017

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...